Company · CIK 0001560258 · SIC 3845 — Electromedical & Electrotherapeutic Apparatus · Nasdaq
electroCore, Inc. · ECOR
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 PForm 4 → | Sep 22, 7:00 am EDT | Thomas J. ErricoDirector | 5,000 | $9.82 | $49,082 | 363,904 | +1.39% | late |
| Sep 11, 2026 PForm 4/A → | Sep 18, 8:43 am EDT | Michael FoxSee Remarks | 5,000 | $9.80 | $49,004 | 130,000 | +4.00% | |
| Sep 11, 2026 AForm 4 → | Sep 14, 6:45 am EDT | Michael FoxSee Remarks | 5,000 | $9.80 | $49,004 | 130,000 | — | amended |
| Sep 9, 2026 AForm 4 → | Sep 10, 5:04 pm EDT | James Charles TheofilosDirector | 11,123 | — | — | 34,670 | — | |
| Sep 9, 2026 AForm 4 → | Sep 10, 4:05 pm EDT | Patricia WilberDirector | 11,123 | — | — | 83,448 | — | |
| Sep 9, 2026 AForm 4 → | Sep 10, 4:05 pm EDT | Elena BonfiglioliDirector | 11,123 | — | — | 41,672 | — | |
| Sep 9, 2026 AForm 4 → | Sep 10, 4:05 pm EDT | Julie Ann GoldsteinDirector | 11,123 | — | — | 112,510 | — | |
| Sep 9, 2026 AForm 4 → | Sep 10, 4:05 pm EDT | Thomas J. ErricoDirector | 15,572 | — | — | 358,904 | — | |
| Sep 9, 2026 AForm 4 → | Sep 10, 4:05 pm EDT | John P GandolfoDirector | 11,123 | — | — | 99,221 | — | |
| Sep 8, 2026 AForm 4 → | Sep 10, 4:05 pm EDT | Michael FoxSee Remarks | 55,000 | — | — | 125,000 | — | |
| Sep 8, 2026 AForm 4 → | Sep 10, 4:05 pm EDT | Joshua S. LevSee Remarks | 55,000 | — | — | 139,889 | — | |
| Aug 21, 2026 SForm 4 → | Aug 25, 5:30 pm EDT | Joshua S. LevCFO and Interim President | 20,000 | $10.01 | $200,120 | 84,889 | −19.1% | |
| Aug 21, 2026 MForm 4 → | Aug 25, 5:30 pm EDT | Joshua S. LevCFO and Interim President | 20,000 | $4.50 | $90,000 | 87,889 | — | |
| Aug 13, 2026 PForm 4 → | Aug 17, 6:19 am EDT | Thomas J. ErricoDirector | 5,000 | $9.85 | $49,272 | 343,332 | +1.48% | |
| Apr 23, 2026 SForm 4 → | Jun 12, 6:12 pm EDT | Daniel S GoldbergerOther | 80,000 | $6.80 | $544,000 | 211,471 | −27.4% | late |
| Jan 15, 2019 SForm 4 → | Jan 17, 8:36 pm EST | Joseph P ErricoSee Remarks, Director, 10% Owner | 50,000 | $4.89 | $244,331 | 582,349 | −7.91% | plan? |
| Jan 11, 2019 JForm 4 → | Jan 15, 5:30 pm EST | Core Ventures II, LLC10% Owner | 1,232,056 | — | — | 6,500,649 | — | plan? |
| Dec 13, 2018 PForm 4 → | Dec 17, 11:10 am EST | Peter S. StaatsChief Medical Officer | 10,000 | $4.83 | $48,300 | 154,636 | +6.91% | plan? |
| Dec 6, 2018 PForm 4 → | Dec 10, 10:25 am EST | Francis R. AmatoChief Executive Officer, Director | 7,500 | $6.53 | $49,009 | 358,831 | +2.13% | plan? |
| Dec 3, 2018 PForm 4 → | Dec 4, 11:35 am EST | Carrie Smith CoxDirector | 7,300 | $6.79 | $49,587 | 11,000 | +197% | plan? |
| Aug 17, 2018 PForm 4 → | Aug 20, 4:31 pm EDT | Carrie Smith CoxDirector | 3,700 | $13.76 | $50,919 | 17,033 | +27.8% | plan? |
| Jun 21, 2018 PForm 4 → | Jun 22, 7:23 pm EDT | Merck Global Health Innovation Fund, LLC10% Owner | 166,666 | $15.00 | $2,499,990 | 3,346,032 | +5.24% | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2026 MForm 4 → | Aug 25, 5:30 pm EDT | Joshua S. LevCFO and Interim President | 20,000 | — | — | 0 | — |